We suspect these drug company payments are just the tip of the iceberg.
Patients need to know that treatments are recommended based on patient need, not pharma company interests. That’s why it’s important to know how much Big Pharma is paying to health-care providers and organizations.
(Shutterstock)
Canada has a lack of transparency about Big Pharma’s payments to health-care providers and organizations. Disclosure is voluntary, and there’s no central data on even the few companies that do report.
A new study suggests the market alone will not deter or punish pharmaceutical companies whose products turn out to have adverse effects after they have been approved.
The Covid-19 pandemic has laid bare Europe’s vulnerability to drug-supply disruption. Still, it remains by far the world leader in pharmaceutical products.
An estimated £300m worth of medicine goes unused in the UK every year. But is it safe to take drugs past their expiry date?
When drug companies and drug regulators, such as Health Canada, sit down together at “pre-submission meetings” this may have a negative impact on public health.
(Shutterstock)
American companies still face enormous uncertainty about how they’ll be doing business in the UK and EU in the coming years, particularly as the April 12 Brexit deadline draws closer.
The lack of transparency seems to be worse in certain disease areas, including diabetes and heart disease.
rawpixel
Clinical guidelines have a big impact on the care you receive and the drugs you’re prescribed. But one in five doctors who write these guidelines have undisclosed ties to drug companies.
The reliability of a new guideline for the management of chronic hepatitis C is questionable, given the financial conflicts of interest documented by its authors.
(Shutterstock)
In the run up to the Global Hepatitis Summit 2018, new guidelines for the management of hepatitis C should come under scrutiny – for financial conflict of interest and quality of evidence.
Could universal pharmacare reduce excessive drug price hikes in Canada? Eric Hoskins, former Ontario Minister of Health, will chair a federal government advisory council to implement a national pharmacare plan. Hoskins is pictured here with federal Minister of Health Ginette Petitpas Taylor.
(THE CANADIAN PRESS/Justin Tang)
The cost of a life-saving drug in Canada is rising by 3,000 per cent. A national pharmacare plan could bring order to this chaotic world of Canadian drug prices.
Have our hopes of a drug treatment for dementia been dashed by drug company Pfizer giving up on research efforts?
from www.shutterstock.com
The Orphan Drug Act was enacted 34 years ago to encourage the development of drugs for rare diseases. Drug companies were guaranteed seven years of exclusivity. Then the rush was on to run up prices.
Even cheap dinners were found to influence prescribing habits.
from www.shutterstock.com.au
An important new study in the United States has found doctors who receive just one cheap meal from a drug company tend to prescribe a lot more of that company’s products.
Medicines drug companies peddle as safe aren’t always.
from www.shutterstock.com.au